Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Ray Kim

Showing results (31-40 of 248) with videos related to

Pageof 25
Sort By:
Seminars in Liver Disease|May 13, 2016
Epidemiology and Healthcare Burden of Acute-on-Chronic Liver FailureAlina M Allen, W Ray Kim
Current Opinion in Gastroenterology|March 13, 2010
Organ allocation for chronic liver disease: model for end-stage liver disease and beyondSumeet K Asrani, W Ray Kim
Clinics in Liver Disease|October 29, 2011
Model for end-stage liver disease: end of the first decadeSumeet K Asrani, W Ray Kim
Gastroenterology|February 5, 2008
Hepatic vein pressure gradient >10 mm Hg: prognostic or reflective?W Ray Kim, Patrick S Kamath
Hepatology (Baltimore, Md.)|February 28, 2007
The model for end-stage liver disease (MELD)Patrick S Kamath, W Ray Kim,
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 27, 2021
Predicting Survival After Liver Transplantation: A Noble Pursuit or a Fool's Errand?Allison J Kwong, W Ray Kim
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 7, 2003
Is the change in MELD score a better indicator of mortality than baseline MELD score?Patrick S Kamath, W Ray Kim
Hepatology (Baltimore, Md.)|August 30, 2008
Benefits of "the benefit model" in liver transplantationW Ray Kim, Walter K Kremers
Clinics in Liver Disease|November 6, 2008
The global impact of hepatic fibrosis and end-stage liver diseaseYoung-Suk Lim, W Ray Kim
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Recurrent hepatocellular carcinoma: it's the virus!W Ray Kim, Gregory J Gores
Pageof 25

Showing results (31-40 of 248) with videos related to

Sort By:
Pageof 25
Seminars in Liver Disease|May 13, 2016
Epidemiology and Healthcare Burden of Acute-on-Chronic Liver FailureAlina M Allen, W Ray Kim
Current Opinion in Gastroenterology|March 13, 2010
Organ allocation for chronic liver disease: model for end-stage liver disease and beyondSumeet K Asrani, W Ray Kim
Clinics in Liver Disease|October 29, 2011
Model for end-stage liver disease: end of the first decadeSumeet K Asrani, W Ray Kim
Gastroenterology|February 5, 2008
Hepatic vein pressure gradient >10 mm Hg: prognostic or reflective?W Ray Kim, Patrick S Kamath
Hepatology (Baltimore, Md.)|February 28, 2007
The model for end-stage liver disease (MELD)Patrick S Kamath, W Ray Kim,
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 27, 2021
Predicting Survival After Liver Transplantation: A Noble Pursuit or a Fool's Errand?Allison J Kwong, W Ray Kim
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 7, 2003
Is the change in MELD score a better indicator of mortality than baseline MELD score?Patrick S Kamath, W Ray Kim
Hepatology (Baltimore, Md.)|August 30, 2008
Benefits of "the benefit model" in liver transplantationW Ray Kim, Walter K Kremers
Clinics in Liver Disease|November 6, 2008
The global impact of hepatic fibrosis and end-stage liver diseaseYoung-Suk Lim, W Ray Kim
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 5, 2013
Recurrent hepatocellular carcinoma: it's the virus!W Ray Kim, Gregory J Gores
Pageof 25